Abstract
It has been estimated that among patients infected with HIV, 5 to 10% will have a non-Hodgkin's lymphoma complicate their course. Patients with HIV are now living longer, attributable to a combination of antiretroviral therapy and improved supportive care for infectious complications, so we can only expect the number of cases of AIDS-related non-Hodgkin's lymphoma (NHL) to rise. There are three important differences between NHL found in the HIV population compared with NHL in those who are immunocompetent.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
